Efeitos da caminhada nórdica na doença de Parkinson: uma revisão sistemática de ensaios clínicos randomizados
DOI:
https://doi.org/10.1590/1809-2950/15861023042016Palavras-chave:
Doença de Parkinson, Caminhada, Revisão, Ensaio Clínico Controlado AleatórioResumo
Várias modalidades de exercício melhoram os sintomas da Doença de Parkinson. Dentre a variedade de exercícios físicos, a caminhada nórdica tem sido utilizada. O objetivo do estudo foi sintetizar a produção científica sobre os efeitos da caminhada nórdica na doença de Parkinson por meio de uma revisão sistemática de ensaios clínicos randomizados. Foram selecionadas as seguintes bases de dados eletrônicas: MEDLINE via Pubmed, Cochrane, PEDro, SCOPUS e Web of Science, e artigos identificados por meio de busca manual, sem restrição de data e idioma. Os revisores avaliaram os artigos completos e os estudos selecionados de acordo com os critérios de elegibilidade. Os dados extraídos foram: identificação da publicação, características dos participantes (sexo, idade, estágio da doença, duração da doença), características da intervenção experimental, características do grupo controle, duração, seguimento, desfechos avaliados e principais resultados. Um programa de caminhada nórdica, realizado com intensidades moderada e alta, com mínimo de 12 sessões de 60 minutos em um período de 6 a 24 semanas promove efeitos positivos na gravidade da doença, marcha, equilíbrio, qualidade de vida, aptidão funcional e função motora em pacientes com doença de Parkinson.Downloads
Referências
Ammal KN, Tarannum S, Thomas B. Epigenetic landscape of
Parkinson’s disease: emerging role in disease mechanisms and
therapeutic modalities. Neurotherapeutic 2013;10(4):698-708.
doi: 10.1007/s13311-013-0211-8.
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM,
Holloway RG, Kieburtz K, et al. Projected number of people
with Parkinson disease in the most populous nations, 2005
through 2030. Neurology 2007;68(5):384-6.
Morris ME. Movement disorders in people with
Parkinson disease: a model for physical therapy. Phys Ter.
;80(6):578-97.
de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease.
Lancet Neurol. 2006;5(6):525-35.
van Nimwegen M, Speelman AD, Hofman-van Rossum
EJ, Overeem S, Deeg DJ, Borm GF, et al. Physical inactivity
in Parkinson’s disease. J Neurol. 2011;258(12):2214-21. doi:
1007/s00415-011-6097-7.
Marsden CD. Parkinson’s disease. J Neurol Neurosurg
Psychiatry. 1994;57(6):672-81.
de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality
of life in patients with Parkinson’s disease: development of a
questionnaire. J Neurol Neurosurg Psychiatry. 1996;61(1):70-4.
Hackney ME, Earhart GM. Effects of dance on movement
control in Parkinson’s disease: a comparison of Argentine tango
and American ballroom. J Rehabil Med. 2009;41(6):475-81.
doi: 10.2340/16501977-0362.
Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J,
et al. Tai chi and postural stability in patients with Parkinson’s
disease. N Engl J Med 2012;366(6):511-9. doi: 10.1056/
NEJMoa1107911.
Corcos DM, Robichaud JA, David FJ, Leurgans SE, Vaillancourt
DE, Poon C, et al. A two-year randomized controlled trial
of progressive resistance exercise for Parkinson’s disease. Mov
Disord 2013;28(9):1230-40. doi: 10.1002/mds.25380.
Vivas J, Arias P, Cudeiro J. Aquatic therapy versus conventional
land-based therapy for Parkinson’s disease: an open-label pilot
study. Arch Phys Med Rehabil. 2011;92(8):1202-10. doi:
1016/j.apmr.2011.03.017.
Bergen JL, Toole T, Elliott RG 3rd, Wallace B, Robinson K,
Maitland CG. Aerobic exercise intervention improves aerobic
capacity and movement initiation in Parkinson’s disease patients.
NeuroRehabilitation. 2002;17(2):161-8.
Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s disease:
a targed for neuroprotection? Lancet Neurol. 2009;8(4):382-97.
doi: 10.1016/S1474-4422(09)70062-6.
Canning CG, Sherrington C, Lord SR, Fung VS, Close JC,
Latt MD, et al. Exercise therapy for prevention of falls in
people with Parkinson’s disease: a protocol for a randomised
controlled trial and economic evaluation. BMC Neurol.
;9:4.doi: 10.1186/1471-2377-9-4.
Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM,
Satterfield S, et al. Diabetes, glucose control, and 9-year cognitive
decline among older adults without dementia. Arch Neurol.
;69(9):1170-5. doi: 10.1001/archneurol.2012.1117.
van Gelder BM, Tijhuis MA, Kalmijn S, Giampaoli S,
Nissinen A, Kromhout D. Physical activity in relation to
cognitive decline in elderly men: the FINE study. Neurology.
;63(12):2316-21.
Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K.
Physical activity and risk of cognitive impairment and dementia
in elderly persons. Arch Neurol. 2001;58(3):498-504.
Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane
P, et al. Exercise is associated with reduced risk for incident
dementia among persons 65 years of age and older. Ann Intern
Med. 2006;144(2):73-81.
Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO.
Exercise treatment for depression: efficacy and dose response.
Am J Prev Med. 2005;28(1):1-8.
Regan C, Katona C, Walker Z, Livingston G. Relationship
of exercise and other risk factors to depression of Alzheimer’s
disease: the LASER-AD study. Int J Geriatr Psychiatry.
;20(3):261-8.
Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert
T, Miller GW. Forced nonuse in unilateral parkinsonian rats
exarcerbates injury. J Neurosci. 2002;22(15):6790-9.
Tschentscher M, Niederseer D, Niebauer J. Health benefits
of Nordic walking: a systematic review. Am J Prev Med.
;44(1):76-84.
Oakley C, Zwierska I, Tew G, Beard JD, Saxton JM. Nordic
poles immediately improve walking distance in patients
with intermittent claudication. Eur J Vasc Endovasc Surg.
;36(6):689-94. doi: 10.1016/j.ejvs.2008.06.036.
Hartvigsen J, Morsø L, Bendix T, Manniche C. Supervised
and non-supervised Nordic walking in the treatment of
chronic low back pain: a single blind randomized clinical
trial. BMC Musculoskelet Disord. 2010;11:30. doi:
1186/1471-2474-11-30.
Gram B, Christensen R, Christiansen C, Gram J. Effects
of nordic walking and exercise in type 2 diabetes mellitus: a
randomized controlled trial. Clin J Sport Med. 2010;20(5):355-
doi: 10.1227/NEU.0b013e3181e56e0a.
Keast ML, Slovinec D’Angelo ME, Nelson CR, Turcotte SE,
McDonnell LA, Nadler RE, et al. Randomized trial of Nordic
walking in patients with moderate to severe heart failure. Can J
Cardiol. 2013;29(11):1470-6. doi: 10.1016/j.cjca.2013.03.008.
Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Kusch M,
Kupsch A, et al. Comparing exercise in Parkinson’s disease – the
Berlin LSVT®BIG study. Mov Disord. 2010;25(12):1902-8.
doi: 10.1002/mds.23212.
van Eijkeren FJ, Reijmers RS, Kleinveld MJ, Minten A, Bruggen
JP, Bloem BR. Nordic walking improves mobility in Parkinson’s
disease. Mov Disord. 2008;23(15):2239-43. doi: 10.1002/
mds.22293.
Silva et al. Nordic walking and Parkinson’s disease
States RA, Spierer DK, Salem Y. Long-term group
exercise for people with Parkinson’s disease: a feasibility
study. J Neurol Phys Ther. 2011;35(3):122-8. doi: 10.1097/
NPT.0b013e31822a0026.
Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors
K, Anderson KE, et al. Randomized clinical trial of 3
types of physical exercise for patients with Parkinson
disease. JAMA Neurol. 2013;70(2):183-90. doi: 10.1001/
jamaneurol.2013.646.
Reuter I, Mehnert S, Leone P, Kaps M, Oechsner M, Engelhardt
M. Effects of a flexibility and relaxation programme, walking,
and Nordic walking on Parkinson’s disease. J Aging Res.
:232473. doi: 10.4061/2011/232473.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred
reporting items for systematic reviews and meta-analyses: the
PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-12.
doi: 10.1016/j.jclinepi.2009.06.005.
Maher CG, Sherrington C, Herbert RD, Moseley AM,
Elkins M. Reliability of the PEDro scale for rating quality of
randomized controlled trials. Phys Ther. 2003;83:713–21.
Shu HF, Yang T, Yu SX, Huang HD, Jiang LL, Gu JW,et al.
Aerobic exercise for Parkinson’s disease: a systematic review
and meta-analysis of randomized controlled trials. PLoS One.
;9(7): e100503. doi: 10.1371/journal.pone.0100503.
Fritz B, Rombach S, Godau J, Berg D, Horstmann T, Grau
S. The influence of Nordic Walking training on sit-to-stand
transfer in Parkinson patients. Gait Posture. 2011;34(2):234-
doi: 10.1016/j.gaitpost.2011.05.004.
Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB.
Effect of exercise on perceived quality of life of individuals with
Parkinson’s disease. J Rehabil Res Dev. 2000;37(5):529-34.
Church TS, Earnest CP, Morss GM. Field testing of physiological
responses associated with Nordic Walking. Res Q Exerc Sport.
;73(3):296-300. doi: 10.1080/02701367.2002.10609023.
Sentinelli F, La Cava V, Serpe R, Boi A, Incani M, Manconi
E, et al. Positive effects of Nordic Walking on anthropometric
and metabolic variables in women with type 2 diabetes mellitus.
Science & Sports. 2015;30(1):25-32. doi: http://dx.doi.
org/10.1016/j.scispo.2014.10.005.
de Lau LM, Verbaan D, Marinus J, van Hilten JJ. Survival
in Parkinson’s disease. Relation with motor and non-motor
features. Parkinsonism Relat Disord. 2014;20(6):613-6. doi:
1016/j.parkreldis.2014.02.030.
Skórkowska-Telichowska K, Kropielnicka K, Bulińska K, Pilch
U, Woźniewski M, Szuba A, et al. Nordic walking in the second
half of life. Aging Clin Exp Res. 2016;28(6):1035-46. doi:
1007/s40520-016-0531-8.
Cugusi L, Solla P, Serpe R, Carzedda T, Piras L, Oggianu M,
et al. Effects of a Nordic Walking program on motor and nonmotor symptoms, functional performance and body composition
in patients with Parkinson’s disease. NeuroRehabilitation.
;37(2):245-54. doi: 10.3233/NRE-151257.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2016 Fisioterapia e Pesquisa
Este trabalho está licenciado sob uma licença Creative Commons Attribution-ShareAlike 4.0 International License.
